This may already have been posted but good to see continued strong support from Hashan and Karst Peak who were Neuren's largest holders at $1 and are backing the company to be an attractive M&A target.
https://www.linkedin.com/posts/hashan-de-silva_why-analysts-love-these-eight-medtech-stocks-activity-7163321989502283776-z7Ef?utm_source=share&utm_medium=member_desktop
"Neuren Pharmaceuticals Limited has had a very successful 2 years however we still see considerable upside when looking at comparable transactions. Orphan drugs has been a hot area for a while and with neuroscience coming back into focus for big pharma, we see Neuren as an attractive target for M&A."
This may already have been posted but good to see continued...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.34 |
Change
-0.410(2.60%) |
Mkt cap ! $1.960B | |||
| Open | High | Low | Value | Volume |
| $15.88 | $15.93 | $15.34 | $6.463M | 415.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 6044 | $15.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.57 | 1411 | 2 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |